Elicio Therapeutics, Inc.
SEC CIK 1601485 · ELTX · last insider filing 2026-02-03
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Connelly Robert | Director · CEO, President and Director | filed 2023 - 2026 |
| Chudnovsky Yekaterina | Director | filed 2023 - 2025 |
| Ruffolo Robert R | Director | filed 2023 - 2025 |
| Adams Julian | Director | filed 2023 - 2025 |
| Wilson Karen J | Director | filed 2021 - 2025 |
| Venkatesan Jay | Director · See Remarks | filed 2021 - 2025 |
| Nissenson Allen | Director | filed 2021 - 2025 |
| Ashe Carol Gail | Director | filed 2023 - 2025 |
| Segal Assaf | Director | filed 2023 - 2023 |
| Goldberg Itzhak | Director · See Remarks | filed 2021 - 2022 |
| Omenn Gilbert S | Director | filed 2021 - 2022 |
| Ganzi Victor F | Director | filed 2021 - 2022 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Haqq Christopher | See Remarks | filed 2023 - 2026 |
| Shah Preetam | See Remarks | filed 2025 - 2026 |
| Demuth Peter | Chief Scientific Officer | filed 2023 - 2026 |
| Piekos Brian | Chief Financial Officer | filed 2023 - 2024 |
| Matthies Annette | Chief Business Officer | filed 2023 - 2023 |
| Curhan Gregory S | See Remarks | filed 2021 - 2022 |
| Rhodes Jennifer J | See Remarks | filed 2021 - 2022 |
| Neylan John F. | See Remarks | filed 2021 - 2022 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.